IPG Photonics Corporation Q2 FY2025 earnings call

Management Statement and Operational Highlights

• Revenue: Second quarter revenue above expectations, up 10% sequentially and 2% year-over-year (excluding divestitures), first year-over-year revenue increase since 2022. Driven by modest demand improvement in multiple markets and geographies and focus on profitable growth.
• Materials Processing: Sequential demand improvement in welding, cutting, and marking applications. China's renewed capacity investments in battery manufacturing drove growth in welding; industrial side saw stabilizing demand. Booking trends encouraging with book-to-bill at approximately 1 on higher revenue.
• Advanced Applications: Achieved record revenue for another quarter driven by higher demand across all categories. Delivered multiple units of first laser counter UAV solution CROSSBOW to Lockheed Martin, with extensive field testing and customer demonstration completed.
• Growth Initiatives: Micromachining delivered strong revenue despite shipment delays; medical with new urology customer driving growth. Plan to continue momentum with additional product introductions in Q4 2025 and beyond.
• Capital Allocation: Focus on organic growth investments and strategic M&A; plan to spend approximately $100 million on CapEx in 2025. Repurchased $30 million of IPG stock. Appointed 5 key leaders to strengthen organization.
• Tariff Response: Effectively adapted to dynamic operating environment by leveraging global manufacturing supply chain flexibility to minimize tariff impact; shipped most orders previously at risk of delay due to tariffs.

Segment Performance

• Materials Processing: Revenue decreased 6% year-over-year due to divestitures and lower sales in cutting, welding, and additive manufacturing applications, partially offset by higher revenue in micromachining and the acquisition of cleanLASER.
• Other Applications: Revenue increased 21% driven by higher sales in medical and advanced applications. Emerging growth products accounted for 54% of sales.
• By Region: North America sales increased 31% sequentially and were down 4% year-over-year; Europe sales were stable sequentially and down 11% year-over-year (excluding $11 million divestitures); Asia sales increased 4% sequentially and 14% year-over-year, benefiting from higher sales in welding, cutting, and advanced applications.

Guidance

• Q3 2025: Expect revenue of $225 million to $255 million, adjusted gross margin between 36% and 38% (including potential slightly higher tariff impact). Operating expenses expected to remain elevated at between $89 million and $91 million. Anticipate adjusted earnings per diluted share in range of $0.05 to $0.35 with ~42.5 million diluted common shares outstanding. Adjusted EBITDA expected to be between $22 million and $36 million.
• Outlook: Expect CapEx to decrease significantly and free cash flow to improve next year.

Risks

• Tariff-related pressure and uncertainty persist. Demand environment remains sensitive to external factors.

Q: Jim Ricchiuti with Needham & Company asked about book-to-bill by region.

A: Mark Milton Gitin responded that book-to-bill was 1 and just about 1 across all regions, also on top of higher revenue.

Q: Ruben Roy with Stifel asked about the opportunity for IPG in directed energy over the next few years and number of customers.

A: Mark Milton Gitin said directed energy is part of leveraging IPG's key technologies, CROSSBOW addresses small drone threats, partnership with Lockheed Martin, and market has opportunities in defense and civilian sectors with extensive testing done.

Q: Ruben Roy asked about Q3 guidance, tariff impact, and second half visibility.

A: Mark Milton Gitin said book-to-bill was 1, able to ship $10 million of the $15 million expected to move into Q3 due to mitigating tariff issues, saw broad-based improvement in markets, but cautious optimism due to tariff uncertainties. Tim Mammen said guidance is usual process, first time in quite a while guiding at midpoint that is mildly positive.

Q: Scott Graham with Seaport Research Partners asked about gross margin.

A: Timothy P. V. Mammen said positive takeaways from gross margin were better manufacturing efficiencies and lower inventory provisions, offset by product mix impact, but cost reduction initiatives are in place.

Q: James Andrew Ricchiuti with Needham & Company asked about systems business.

A: Mark Milton Gitin said cleanLASER is going well, also seeing increases in other areas of systems, including micromachining systems and LightWELD in welding.

Q: James Andrew Ricchiuti asked about Medical business competitive environment.

A: Mark Milton Gitin said urology is key area, strong position on thulium lasers in urology, new customer driving share growth in marketplace.

Q: Scott Graham with Seaport Research Partners asked about gross margin minus 500 basis points.

A: Timothy P. V. Mammen said positive takeaways were better manufacturing efficiencies and lower inventory provisions, offset by product mix impact, with cost reduction initiatives in place.

Q: Scott Graham asked about order book progression.

A: Timothy P. V. Mammen said total value of bookings increased year-over-year, tone during quarter significantly improved compared to a year ago, bookings not back loaded.

Q: Mark S. Miller with The Benchmark Company asked about welding market outside of China and margin profile of backlog.

A: Mark Milton Gitin said seen good growth in welding globally, including in US; Timothy P. V. Mammen said mix on backlog is not fundamentally different going into the quarter.